VISMODEGIB IN COMBINATION WITH A REPLICATION-DEFICIENT TYPE 5 ADENOVIRUS FOR EXPRESSION OF INTERFERON GAMMA FOR THE TREATMENT OF SKIN CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230065168A1
SERIAL NO

17709208

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are methods of treating skin cancer in an individual in need thereof by administering to the individual vismodegib and a replication-deficient type 5 adenovirus for expression of interferon gamma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENENTECH INC1 DNA WAY SOUTH SAN FRANCISCO CA 94080-4990

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Leong, Clement South Melbourne, AU 8 18
McKenna,, JR Edward F Calabash, US 1 0
Pietersz, Geoffrey South Melbourne, AU 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation